| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $1.6M | — |
| SG&A Expense | $22K | +167.0% |
| Operating Income | -$91K | +37.8% |
| Interest Expense | $525K | -0.3% |
| Net Income | -$596K | +8.5% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $693K | -9.3% |
| Current Assets | $694K | -9.3% |
| Total Assets | $694K | -9.3% |
| Current Liabilities | $4.0M | +14.9% |
| Total Liabilities | $14.5M | +3.7% |
| Stockholders' Equity | -$13.9M | -4.5% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71K | +43.4% |